INTRAPERITONEAL SECRETION OF INTERLEUKIN-6 DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

被引:80
作者
GOLDMAN, M
VANDENABEELE, P
MOULART, J
AMRAOUI, Z
ABRAMOWICZ, D
NORTIER, J
VANHERWEGHEM, JL
FIERS, W
机构
[1] UNIV LIBRE BRUXELLES,PLURIDISCIPLINAIRE RECH EXPTL BIOMED LAB,B-1050 BRUSSELS,BELGIUM
[2] STATE UNIV GHENT,MOLEC BIOL LAB,B-9000 GHENT,BELGIUM
来源
NEPHRON | 1990年 / 56卷 / 03期
关键词
cytokines; interleukin-6; peritoneal dialysis; peritonitis;
D O I
10.1159/000186154
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-6 (IL-6) was determined in serum and peritoneal dialysis effluent (PDE) of patients on chronic ambulatory peritoneal dialysis (CAPD) by a biological assay measuring the proliferation of the IL-6-dependent 7TD1 cell line. Six patients free of peritonitis displayed low but significant levels of IL-6 (mean ± 42 pg/ml) in PDE, while IL-6 was undetectable in serum. In 6 patients with staphylococcal peritonitis, a tremendous increase in PDE levels of IL-6 was noted (range: 5,832-37,491 pg/ml), while serum IL-6 remained either undetectable or on a low level except in one case. After 5 days of antibiotic treatment, IL-6 levels in PDE returned to basal values. We conclude that CAPD results in an intraperitoneal secretion of IL-6 which is markedly but transiently increased during peritonitis episodes.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 12 条
[1]  
DINARELLO CA, 1986, FASEB J, V45, P2545
[2]  
GANGULY R, 1980, J RETICULOENDOTH SOC, V27, P303
[3]  
HOUSSIAU FA, 1988, CLIN EXP IMMUNOL, V71, P320
[4]   INTERLEUKIN-6 IN SYNOVIAL-FLUID AND SERUM OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES [J].
HOUSSIAU, FA ;
DEVOGELAER, JP ;
VANDAMME, J ;
DEDEUXCHAISNES, CN ;
VANSNICK, J .
ARTHRITIS AND RHEUMATISM, 1988, 31 (06) :784-788
[5]   POTENTIAL ROLE FOR INTERLEUKIN-1 IN FIBROSIS ASSOCIATED WITH CHRONIC AMBULATORY PERITONEAL-DIALYSIS [J].
KRANE, SM ;
GOLDRING, MB .
BLOOD PURIFICATION, 1988, 6 (03) :173-177
[6]  
LAMPERI S, 1986, T AM SOC ART INT ORG, V32, P35
[8]  
SHALDON S, 1984, T AM SOC ART INT ORG, V30, P193
[9]  
TAGA T, 1987, J EXP MED, V166, P964
[10]  
VANDAMME J, 1988, J IMMUNOL, V140, P1534